Skip to main content

Lisinopril

NDC 82868-009 · Northwind Health Company, LLC

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength30 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

82868-009-30 — 30 TABLET in 1 BOTTLE, PLASTIC (82868-009-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

76282-730 — LISINOPRIL, 76282-731 — LISINOPRIL, 76282-732 — LISINOPRIL, 76282-733 — LISINOPRIL, 76420-340 — Lisinopril, 76420-341 — Lisinopril, 76420-342 — Lisinopril, 76420-343 — Lisinopril, 76420-344 — Lisinopril, 76420-345 — Lisinopril, 80425-0207 — Lisinopril and Hydrochlorothiazide, 82009-062 — Lisinopril, 82009-063 — Lisinopril, 82009-064 — Lisinopril, 82009-065 — Lisinopril, 82009-066 — Lisinopril, 82804-307 — Lisinopril and Hydrochlorothiazide Tablets, 87441-047 — Lisinopril, 87441-048 — Lisinopril, 87441-049 — Lisinopril, +342 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels